European Patent Office

T 0755/96 (Camptothecin derivatives/RESEARCH TRIANGLE INSTITUTE) vom 06.08.1999

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:1999:T075596.19990806
Datum der Entscheidung
6. August 1999
Aktenzeichen
T 0755/96
Antrag auf Überprüfung von
-
Anmeldenummer
90310085.7
IPC-Klasse
C07D 491/22
Verfahrenssprache
Englisch
Verteilung
Im Amtsblatt des EPA veröffentlicht (A)
Amtsblattfassungen
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Analogue de la 10,11-méthylènedioxy-20(RS)camptothécine et de la 10,11-méthylènedioxy-20(s)-camptothécine
Name des Antragstellers
RESEARCH TRIANGLE INSTITUTE
Name des Einsprechenden
-
Kammer
3.3.01
Leitsatz

In ex parte proceedings, Rule 71a EPC gives the Examining Division a discretion to admit or refuse amended claims until a decision is issued under Article 97 EPC. This discretion must be exercised by considering all relevant factors which arise in a particular case and by balancing the Applicant's interest in obtaining a proper patent protection for his claimed invention and the EPO's interest in bringing the examination procedure to a speedy close by the issue of a decision. If in exercising said discretion amended claims are not admitted, the reasons therefore must be given. The assessment that they were filed too late under Rule 71a EPC does not represent an adequate reasoning in conformity with Rule 68(2) EPC.

Schlagwörter
Discretion to admit or refuse amended claims under Rule 71a EPC (yes)
Adequate reasons for not admitting amended claims (no)
Substantial procedure violation (yes)
Reimbursement of the appeal fee (yes)
Remittal to the first instance for further prosecution
Orientierungssatz
-

ORDER

For these reasons, it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the Examining Division for further prosecution.

3. The request for reimbursement of the appeal fee is allowed.